06:11pm Thursday 19 October 2017

Scientists develop new approach to study how genetic variants affect gene expression



Each individual carries a unique version of the human genome. Genetic differences can influence traits such as height, weight and vulnerability to disease, but precisely what these genetic variants are and how they exercise their impact is mostly unknown. UCLA researchers have now developed a novel approach to study the ways in which these individual differences affect how strongly certain genes are “expressed” — that is, how they are translated into the proteins that do the actual work in cells.
Using different strains of a yeast called Saccharomyces cerevisiae, a single-celled fungus, they studied hundreds of thousands of genetically different yeast cells — orders of magnitude more than previously examined — making their approach statistically powerful and significantly more revealing about how genetic differences influence gene expression.

They also directly studied protein levels, an approach that differed from earlier work, which focused on levels of messenger RNA (mRNA), the intermediate molecules that cells use to read genes and translate them into proteins. While mRNAs are easier to measure than proteins, their levels don’t always correspond to protein levels.

The two-and-a-half-year study found that the protein expression of a typical gene is influenced by many more genetic variants than previously thought and that the effects of genetic differences on mRNA levels corresponded much more closely to the effects on protein expression than seen earlier. Additionally, there is a complex web of variants that affects a large fraction of the proteins in cells.

The work could shed light on the study of disease risk in humans, as genetic variants that influence disease often act by affecting the expression of genes. Clinical applications may eventually flow from a better understanding of the process of genetic variants and protein expression.
Authors include Frank W. Albert, a UCLA postdoctoral researcher, and Leonid Kruglyak, a UCLA professor of human genetics and biological chemistry and a Howard Hughes Medical Institute investigator.
The study was funded by the National Institutes of Health (RO1 GM102308), the Howard Hughes Medical Institute, the McDonnell Foundation, the National Science Foundation and the German Research Foundation (DFG).
The research appears in the Jan. 8 early online edition of the journal Nature. A copy of the full study is also available.

Share on:

MORE FROM Genetics and Birth Defects

Health news